|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:TRIM32-DDX21 (FusionGDB2 ID:94068) |
Fusion Gene Summary for TRIM32-DDX21 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TRIM32-DDX21 | Fusion gene ID: 94068 | Hgene | Tgene | Gene symbol | TRIM32 | DDX21 | Gene ID | 22954 | 54606 |
| Gene name | tripartite motif containing 32 | DEAD-box helicase 56 | |
| Synonyms | BBS11|HT2A|LGMD2H|LGMDR8|TATIP | DDX21|DDX26|NOH61 | |
| Cytomap | 9q33.1 | 7p13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | E3 ubiquitin-protein ligase TRIM3272 kDa Tat-interacting proteinRING-type E3 ubiquitin transferase TRIM32TAT-interactive protein, 72-KDtripartite motif-containing protein 32zinc-finger protein HT2A | probable ATP-dependent RNA helicase DDX5661-kd nucleolar helicaseATP-dependent 61 kDa nucleolar RNA helicaseDEAD (Asp-Glu-Ala-Asp) box helicase 56DEAD (Asp-Glu-Ala-Asp) box polypeptide 56DEAD box protein 21DEAD box protein 56DEAD-box RNA helicasen | |
| Modification date | 20200327 | 20200313 | |
| UniProtAcc | . | Q9NR30 | |
| Ensembl transtripts involved in fusion gene | ENST00000450136, ENST00000373983, | ENST00000354185, | |
| Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 36 X 11 X 14=5544 |
| # samples | 3 | 37 | |
| ** MAII score | log2(3/8*10)=1.90689059560852 | log2(37/5544*10)=-3.9053300816209 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: TRIM32 [Title/Abstract] AND DDX21 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | TRIM32(119461323)-DDX21(70738619), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | TRIM32-DDX21 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. TRIM32-DDX21 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. TRIM32-DDX21 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TRIM32 | GO:0000209 | protein polyubiquitination | 18632609 |
| Hgene | TRIM32 | GO:0016567 | protein ubiquitination | 16816390 |
| Hgene | TRIM32 | GO:0030307 | positive regulation of cell growth | 18632609 |
| Hgene | TRIM32 | GO:0030335 | positive regulation of cell migration | 18632609 |
| Hgene | TRIM32 | GO:0032897 | negative regulation of viral transcription | 18248090 |
| Hgene | TRIM32 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 23077300 |
| Hgene | TRIM32 | GO:0045087 | innate immune response | 18248090 |
| Hgene | TRIM32 | GO:0045787 | positive regulation of cell cycle | 18632609 |
| Hgene | TRIM32 | GO:0045862 | positive regulation of proteolysis | 18632609 |
| Hgene | TRIM32 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 23077300 |
| Hgene | TRIM32 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 23077300 |
| Hgene | TRIM32 | GO:1902187 | negative regulation of viral release from host cell | 18248090 |
| Hgene | TRIM32 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 18632609 |
| Fusion gene breakpoints across TRIM32 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across DDX21 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | CN278368 | TRIM32 | chr9 | 119461323 | + | DDX21 | chr10 | 70738619 | + |
Top |
Fusion Gene ORF analysis for TRIM32-DDX21 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000450136 | ENST00000354185 | TRIM32 | chr9 | 119461323 | + | DDX21 | chr10 | 70738619 | + |
| In-frame | ENST00000373983 | ENST00000354185 | TRIM32 | chr9 | 119461323 | + | DDX21 | chr10 | 70738619 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000373983 | TRIM32 | chr9 | 119461323 | + | ENST00000354185 | DDX21 | chr10 | 70738619 | + | 4997 | 2308 | 55 | 711 | 218 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000373983 | ENST00000354185 | TRIM32 | chr9 | 119461323 | + | DDX21 | chr10 | 70738619 | + | 0.001908144 | 0.9980919 |
Top |
Fusion Genomic Features for TRIM32-DDX21 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TRIM32-DDX21 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:119461323/chr10:70738619) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | DDX21 |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: RNA helicase that acts as a sensor of the transcriptional status of both RNA polymerase (Pol) I and II: promotes ribosomal RNA (rRNA) processing and transcription from polymerase II (Pol II) (PubMed:25470060, PubMed:28790157). Binds various RNAs, such as rRNAs, snoRNAs, 7SK and, at lower extent, mRNAs (PubMed:25470060). In the nucleolus, localizes to rDNA locus, where it directly binds rRNAs and snoRNAs, and promotes rRNA transcription, processing and modification. Required for rRNA 2'-O-methylation, possibly by promoting the recruitment of late-acting snoRNAs SNORD56 and SNORD58 with pre-ribosomal complexes (PubMed:25470060, PubMed:25477391). In the nucleoplasm, binds 7SK RNA and is recruited to the promoters of Pol II-transcribed genes: acts by facilitating the release of P-TEFb from inhibitory 7SK snRNP in a manner that is dependent on its helicase activity, thereby promoting transcription of its target genes (PubMed:25470060). Functions as cofactor for JUN-activated transcription: required for phosphorylation of JUN at 'Ser-77' (PubMed:11823437, PubMed:25260534). Can unwind double-stranded RNA (helicase) and can fold or introduce a secondary structure to a single-stranded RNA (foldase) (PubMed:9461305). Together with SIRT7, required to prevent R-loop-associated DNA damage and transcription-associated genomic instability: deacetylation by SIRT7 activates the helicase activity, thereby overcoming R-loop-mediated stalling of RNA polymerases (PubMed:28790157). Involved in rRNA processing (PubMed:14559904, PubMed:18180292). May bind to specific miRNA hairpins (PubMed:28431233). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (By similarity). {ECO:0000250|UniProtKB:Q9JIK5, ECO:0000269|PubMed:11823437, ECO:0000269|PubMed:14559904, ECO:0000269|PubMed:18180292, ECO:0000269|PubMed:25260534, ECO:0000269|PubMed:25470060, ECO:0000269|PubMed:25477391, ECO:0000269|PubMed:28431233, ECO:0000269|PubMed:28790157, ECO:0000269|PubMed:9461305}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 217_396 | 0 | 784.0 | Domain | Helicase ATP-binding | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 429_573 | 0 | 784.0 | Domain | Helicase C-terminal | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 186_214 | 0 | 784.0 | Motif | Q motif | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 339_342 | 0 | 784.0 | Motif | DEAD box | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 230_237 | 0 | 784.0 | Nucleotide binding | ATP | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 724_748 | 0 | 784.0 | Region | Note=3 X 5 AA repeats | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 724_728 | 0 | 784.0 | Repeat | Note=1 | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 734_738 | 0 | 784.0 | Repeat | Note=2 | |
| Tgene | DDX21 | chr9:119461323 | chr10:70738619 | ENST00000354185 | 0 | 15 | 744_748 | 0 | 784.0 | Repeat | Note=3 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 138_197 | 0 | 654.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 138_197 | 0 | 654.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 2_6 | 0 | 654.0 | Compositional bias | Note=Poly-Ala |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 2_6 | 0 | 654.0 | Compositional bias | Note=Poly-Ala |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 358_401 | 0 | 654.0 | Repeat | Note=NHL 1 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 415_458 | 0 | 654.0 | Repeat | Note=NHL 2 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 459_499 | 0 | 654.0 | Repeat | Note=NHL 3 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 562_605 | 0 | 654.0 | Repeat | Note=NHL 4 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 606_646 | 0 | 654.0 | Repeat | Note=NHL 5 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 358_401 | 0 | 654.0 | Repeat | Note=NHL 1 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 415_458 | 0 | 654.0 | Repeat | Note=NHL 2 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 459_499 | 0 | 654.0 | Repeat | Note=NHL 3 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 562_605 | 0 | 654.0 | Repeat | Note=NHL 4 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 606_646 | 0 | 654.0 | Repeat | Note=NHL 5 |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 103_133 | 0 | 654.0 | Zinc finger | B box-type |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000373983 | + | 1 | 2 | 20_65 | 0 | 654.0 | Zinc finger | RING-type |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 103_133 | 0 | 654.0 | Zinc finger | B box-type |
| Hgene | TRIM32 | chr9:119461323 | chr10:70738619 | ENST00000450136 | + | 1 | 2 | 20_65 | 0 | 654.0 | Zinc finger | RING-type |
Top |
Fusion Gene Sequence for TRIM32-DDX21 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >94068_94068_1_TRIM32-DDX21_TRIM32_chr9_119461323_ENST00000373983_DDX21_chr10_70738619_ENST00000354185_length(transcript)=4997nt_BP=2308nt GGCAGGCGGGTGGGCTGCCGGCGGTGGACTCGTCGGAGCCGCGGGCGGTCAGGCAATGAACTGCCAGGGGCTGATTGGTGTGACTGACAG CTATGATAACTCCCTCAAGGTATATACCTTGGATGGCCACTGCGTGGCCTGTCACAGGAGCCAGCTGAGCAAACCATGGGGTATCACAGC CTTGCCATCTGGCCAGTTTGTAGTAACCGATGTGGAAGGTGGAAAGCTTTGGTGTTTCACAGTTGATCGAGGATCAGGGGTGGTCAAATA CAGCTGCCTATGTAGTGCTGTGCGGCCCAAATTTGTCACCTGTGATGCTGAGGGCACCGTCTACTTCACCCAGGGCTTAGGCCTCAATCT GGAGAATCGGCAGAATGAGCACCACCTGGAGGGTGGCTTTTCCATTGGCTCTGTAGGCCCTGATGGGCAGCTGGGTCGCCAGATTAGCCA CTTCTTCTCGGAGAATGAGGATTTCCGCTGCATTGCTGGCATGTGTGTGGATGCTCGTGGTGATCTCATCGTGGCTGACAGTAGTCGCAA GGAAATTCTCCATTTTCCTAAGGGTGGGGGCTATAGTGTCCTTATTCGAGAGGGACTTACCTGTCCGGTGGGCATAGCCCTAACTCCTAA GGGGCAGCTGCTGGTCTTGGACTGTTGGGATCATTGCATCAAGATCTACAGCTACCATCTGAGAAGATATTCCACCCCATAGGGGATGAG AAATTATCAGTTTCTTCTGCTCCCAAGCCAACTTCCCTTCCCTTAGTTCTTGGTTGTTAGTGGCACATGCAGAATAGACTCAGCCTATGT CCTGATTCCAGCTGGGTAGTTCTAGAACTTCAGAAGCTCCATCTTTTAATGTTTTTATTTGTTATGTCCCCCTCCCCGCTTCCCACCTAA ATTTAGAGCTTTAAAAGATGCACTGCCCAAATAGGACACACGATGGTGTTAGCTGAAGTTTGATTAGCAATTAGGCACTTCCAAGGCTTT AGTAGAGAGAGCCACTTTAGCCCTTTGTGCCATGTTTGAAATTTGCCCTTGTATTAAATCCTTGATTTTTTCCCATTTGGCTTTGATGCC CTTGATCCATTGTTTCCTTCCTACTATAATGTGCTTCATCTGTGACACTTTCTCTTGAACTCTGATTGGATTCACTGTGCATGCTTCAGT GGGATCTGCTCCACCTTTCAGTGACATTTAAGACATCATATTCCCGTAACATTATGTCTCAGTCTGATCGTCTTTACCAGTATGAAAGTC ATTCATTTAGTGCTACCAAAGGGGATACACAAGCCCTTTAGGAAGCAGTACCTCTCGCCTGGAGGATCTGTGCCATCTTGGATTGAGAAT TGCAGATGTGACAGAATGGATTGACCCTAGTTGGTTGGTATTGATGACTTCAGCCTGGAAATTGCTTGCCTTTTAAAGAAGCATATATGG GTTGGAATTATGCCAAAGCATAGGAAGCTGGGAATAAGCAAACAAATGCTGATATAGTCAGCAAATTTGGATAGTCTCTAGGGCTCATCA TTTTTCATACTACCTCTCTCTTCTGGCCTGTGTCTAAGGAATTGTACAACATAGGCCAGGGCCAACAAAGTGGAGAGGTGGACACATTTT CATGTTCATTACTAAAACAAACAGCAAAACTATTGGTTTGTTATTCTGTGTTTTCCTCAAGTCAGTACATACTATTTGGTTTCAGGATTT CTTTCCATTTCTCTATCAAGCATTAAATAATTGAGAACTGTTTCTTCATCTCTGGTGTTCATGTCTTTTAATTAAATACGGAATTTTGGA GATGATAAGAGGGATAACCTGCGCTATGCCATTTTGCTTCCTTATCTCACTGTGTTCTTTCAGAGTGTAGATATCTACCCAGGTCAAAAT TCAGCCAAAAGCACTATTATGTAAAGATAATAATCCAAATCTTTCTCCCAAATACATGTGTACAGAATCATCCCCCAAGGTTTAGAGTCA CCAATACCCTATTCTGAGCTTCTGCTGTATGTTTTATGTTTATAATTACAGTTCACAAAAAGGAAGTTAGTCTTGTTTTTAAGATCAGAA GTGGGTGAGAGGACCTGTGATGAGGTTCCTGAGGGTTTGGTGTTTACTAAGTAATATATCTTACTCTAGGTGCAGGGCTGATGGCAAGCC AAAGAGCAACTGCCTTACTTTGATGTAAACAAAATTTGCTAAACTGAGCTGCTCAAAATTGTTTTTATGGTAGTAGTGTTTCTTTGGATT GTATCATAATAGCTGCCAAAGGATAGGTAAAGAGGTCATTAAAATGATGTTGAACTAGAGTGCTCAATTGAAATGCCAAATATTAGTTAT GCTTGGAAAGAACTTAAAGAGCAGCTGGGCGAGGAGATTGATTCCAAAGTGAAGGGAATGGTTTTTCTCAAAGGAAAGCTGGGTGTTTGC TTTGATGTACCTACCGCATCAGTAACAGAAATACAGGAGAAATGGCATGATTCACGACGCTGGCAGCTCTCTGTGGCCACAGAGCAACCA GAACTGGAAGGACCACGGGAAGGATATGGAGGCTTCAGGGGACAGCGGGAAGGCAGTCGAGGCTTCAGGGGACAGCGGGACGGAAACAGA AGATTCAGAGGACAGCGGGAAGGCAGTAGAGGCCCGAGAGGACAGCGATCAGGAGGTGGCAACAAAAGTAACAGATCCCAAAACAAAGGC CAGAAGCGGAGTTTCAGTAAAGCATTTGGTCAATAATTAGAAATAGAAGATTTATATAGCAAAAAGAGAATGATGTTTGGCAATATAGAA CTGAACATTATTTTTCATGCAAAGTTAAAAGCACATTGTGCCTCCTTTTGACCACTTGCCAAGTCCCTGTCTCTTTCAGACACAGACAAG CTTCATTTAAATTATTTCATCTGATCATTATCATTTATAACTTTATTGTTACTTCTTCATCAGTTTTTCCTTTTGAAAGGTGTATGAATT CATTACATTTTTATTCTAATGTATTATCTGTAGATTAGAAGATAAAATCAAGCATGTATCTGCCTATACTTTGTGAGTTCACCTGTCTTT ATACTCAAAAGTGTCCCTTAATAGTGTCCTTCCCTGAAATAAATACCTAAGGGAGTGTAACAGTCTCTGGAGGACCACTTTGAGCCTTTG GAAGTTAAGGTTTCCTCAGCCACCTGCCGAACAGTTTCTCATGTGGTCCTATTATTTGTCTACTGAGACTTAATACTGAGCAATGTTTTG AAACAAGATTTCAAACTAATCTGGGTTGTAATACAGTTTATACCAGTGTATGCTCTAGACTTGGAAGATGTAGTATGTTTGATGTGGATT ACCTATACTTATGTTCGTTTTGATACATTTTTAGCTTCTCATTATAAGGTGATTCATGCTTTAGTGAATTCTTCATAGATAGTATATATA AAAGTACATTTTAATAGAAAGCCAGGGTTTTAAGGAATTTCACATGTATAAGGTGGCTCCATAGCTTTATTTGTAAGTAGGCTGGATAAA TGGTGCTTAAATGGTAATGTACTCCACTTCTTCCTATTGGAAGATTAACATTATTTACCAAGAAGGACTTAAGGGAGTAGGGGGCGCAGA TTAGCATTGCTCAAGAGTATGTAAAAAAAAAAAAAAAAAAAAAGAACCAAACCACTGGAAATAATCAAATGCAAAAAGGTAACAAATTCA TAACTGGAAAGCAAAGAGAAGAACAAGTATGATTTGGATGATAAAGCATTGTTTTAATGGTGAAAACTTCACAGATCACTAATGTTTCTA GAGGTTAACTTCAAGTGGGCAAGCTGGGGTTTTTAGGTAGTCAGTGGCCTAGTTCCTAAAGCCACAGTATAGGATCTGTTAAACTGAATG TCTGTTGAAAGTTTGTTTTAGCTGCTTGGAGGCTTCCTTTTAAGACAAACTGTATGTGATTAAGTTGTTTTGAGGGAACTGAAGAACCTG ATGTAGCCCCTGGCCAGATAACTGCCTGATTTCTCAGATATTATTTCTCTGGGAAACATTCTACATAGCACAGGAGCTTAAGAGTGGCAT TATCTTCTCGCCTTAATTTCCAGAGATTATTTCTGTACTGAGAATCCTGGAACTACTATGCTAGGAAATTTAAAGCTGCATGGTCTGTCT TGTTTTCATTTAATTATTGTGAATACCTAGAATCTTTCTTGGTCCTGATTTCTCTTGCTTAATCCAGTCTTTATCTCTAACTGCCCCTTA TTTGATCACCATGTACTAGGAGCTCTGATAGCCAGCTCAGCTCCTAATCCTTGAGGCAACATTCTTTTTCTATTTGAACTTCAGTTCTGT CCTTGAATCCCGACTAGATATTTCTTGCCCTCTGGTCTCAGAATTCTCTTGGCTTTTATTCCTTGATCCACTTGCCAGTTTTATCACTTT ACCCTTGTTCCTCATGGCTTCCCATCAAGCCATGGGTATTAGGTGACAGTGTAATTTATTAGATTCTGGTTTTGCCCAAATACTGGGCAT GCTTTAATAATAACTGAACCATTTCATTATTTGGATAGGCATGGGTACCTTATCAAGCAGATTAAAAGGATATGGTACCCGTCCTTTAGA AAAGAACAGCTAAAACCTTGTTGTGGATTATGGATTTAGCCTAAAGAAAAATAATCTGGCATAAATTAAGAGTAAGAGAGAAGATTAATA GAAATTTCACTTCACATAACTTAAAACATGGCTATTTCAATAAAGGACTAAAGTTTCTCCTGGATCCCAGAATTCAACCTGTATTTATAA ATGTATAATGTATTTAGCTACTTTTTGGTTTAAATGAACTTGTTGGGTTAGCTTGGTAAATGTTATAATTTTTACTATTTTCTACAAAGA AAATATTTTCTAATTTAAGTTGGAGCTATCTGTGCAGCAGTTTCTCTACAGTTGTGCATAAATGTTTTTACTATAAAATGAGCTAATGTA >94068_94068_1_TRIM32-DDX21_TRIM32_chr9_119461323_ENST00000373983_DDX21_chr10_70738619_ENST00000354185_length(amino acids)=218AA_BP= MNCQGLIGVTDSYDNSLKVYTLDGHCVACHRSQLSKPWGITALPSGQFVVTDVEGGKLWCFTVDRGSGVVKYSCLCSAVRPKFVTCDAEG TVYFTQGLGLNLENRQNEHHLEGGFSIGSVGPDGQLGRQISHFFSENEDFRCIAGMCVDARGDLIVADSSRKEILHFPKGGGYSVLIREG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for TRIM32-DDX21 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TRIM32-DDX21 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TRIM32-DDX21 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies